ATOPIC DERMATITIS (AD)

This study aims to find out which of two existing eczema creams works better for children with mild to moderate atopic dermatitis. It will involve 66 children aged 2 to 18, who will apply one of the creams twice a day for 28 days. Researchers will compare how well each cream clea…

This study is testing an already-approved eczema medication called ivarmacitinib in a real-world setting. It will enroll 1000 adolescents and adults with moderate-to-severe atopic dermatitis to see how well it controls itching, clears skin rashes, and prevents flare-ups. The main…

This study aims to see if a new drug called SIM0278 can safely reduce the severity of moderate to severe eczema (atopic dermatitis) in adults. About 184 participants will be randomly assigned to receive one of three different doses of the drug or a placebo for 16 weeks. The main …

This study aims to see if a new injectable medication called GS101 works as well as the established treatment Dupixent for controlling moderate-to-severe eczema. About 572 adults with long-term eczema will receive either GS101 or Dupixent injections to compare their effectiveness…

This study is testing a new foam medication called OPA-15406 to see if it can better control eczema symptoms in children compared to a placebo foam. It will involve about 200 children with moderate eczema, measuring how well their skin clears after 4 weeks of treatment. A smaller…

This study is testing whether a prescription cream called crisaborole works better than a placebo cream for controlling mild to moderate eczema. Teens and adults with eczema will apply the cream twice a day for four weeks. Researchers will check if the skin clears up significantl…

This early-stage study is testing a new drug called S-4321 in adults with autoimmune diseases like rheumatoid arthritis, psoriasis, lupus, or eczema. The main goal is to check the drug's safety, how the body processes it, and look for early signs it might help control these condi…

This study is testing if a new foam containing the drug OPA-15406 is better than a foam without the drug at improving skin in adults with moderate atopic dermatitis (eczema). About 156 participants will apply the foam to their skin for 4 weeks. The main goal is to see if the acti…

This study aims to find out if teens with eczema prefer to apply moisturizer while still in the shower or bath, or after they have towel-dried. Researchers will compare both methods over two months to see which one feels better and if it makes a difference for skin hydration and …

This study creates a national registry to track how well advanced eczema treatments work for patients in Costa Rica. Researchers will follow 50 people with moderate-to-severe eczema who are already receiving treatments like dupilumab or JAK inhibitors as part of their regular car…

This study aims to understand how the brain processes itch and discomfort in people with mild to moderate eczema. Researchers will measure brainwave activity using a special headband in 20 adults after they apply a standard skin cream or plain water. The goal is to gather informa…